Clinical Trials
7 trialsNCT06117878 2023-11-07
Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT05851456 2023-05-09
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT04886765 2021-05-14
A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma
AlaMab Therapeutics (Shanghai) Inc.
Phase 1/2 Unknown
NCT04864821 2021-05-06
Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT03676985 2018-09-26
A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma
Lee's Pharmaceutical Limited
Phase 1/2 Unknown
NCT01002092 2014-09-03
A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Phase 2 Unknown
NCT01242072 2012-07-18
Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies
Alaunos Therapeutics
Phase 1 Unknown